表紙:抗体薬物複合体 (ADC) の世界市場 (2021年) - COVID-19による成長と変化 (2030年まで)
市場調査レポート
商品コード
1028862

抗体薬物複合体 (ADC) の世界市場 (2021年) - COVID-19による成長と変化 (2030年まで)

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
抗体薬物複合体 (ADC) の世界市場 (2021年) - COVID-19による成長と変化 (2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の抗体薬物複合体 (ADC) 市場について調査分析し、市場の特徴、市場規模と成長率、市場セグメンテーション、地域別・国別の内訳、競合情勢、市場シェア、動向と戦略について、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 抗体薬物複合体 (ADC) 市場の特徴

第3章 抗体薬物複合体 (ADC) 市場の動向と戦略

第4章 抗体薬物複合体 (ADC) に対するCOVID-19の影響

第5章 抗体薬物複合体 (ADC) の市場規模と成長率

  • 世界の抗体薬物複合体 (ADC) 市場実績 (金額)
  • 世界の抗体薬物複合体 (ADC) 市場予測 (金額)

第6章 抗体薬物複合体 (ADC) 市場セグメンテーション

  • 世界の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • モノクローナル抗体
  • リンカー
  • 薬物/毒素
  • その他
  • 世界の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 血液がん
  • 乳がん
  • 卵巣がん
  • 肺がん
  • 脳腫瘍
  • その他
  • 世界の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)
  • Adcertis
  • Kadcyla
  • その他
  • 世界の抗体薬物複合体 (ADC) 市場:技術別、実績と予測 (金額)
  • イムノゲン技術
  • Seattle Genetics技術
  • Immunomedics技術
  • その他
  • 世界の抗体薬物複合体 (ADC) 市場:エンドユーザー別、実績と予測 (金額)
  • 病院
  • クリニック
  • その他

第7章 抗体薬物複合体 (ADC) 市場の地域別・国別分析

  • 世界の抗体薬物複合体 (ADC) 市場:地域別、実績と予測 (金額)
  • 世界の抗体薬物複合体 (ADC) 市場:国別、実績と予測 (金額)

第8章 アジア太平洋地域の抗体薬物複合体 (ADC) 市場

  • アジア太平洋地域の抗体薬物複合体 (ADC) 市場概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府のイニシアチブ、規制、規制機関、主要な協会、課税、法人税構造、投資、主要企業
  • アジア太平洋地域の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • アジア太平洋地域の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • アジア太平洋地域の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第9章 中国の抗体薬物複合体 (ADC) 市場

  • 中国の抗体薬物複合体 (ADC) 市場概要
  • 中国の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 中国の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 中国の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第10章 インドの抗体薬物複合体 (ADC) 市場

  • インドの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • インドの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • インドの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第11章 日本の抗体薬物複合体 (ADC) 市場

  • 日本の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 日本の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 日本の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第12章 オーストラリアの抗体薬物複合体 (ADC) 市場

  • オーストラリアの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • オーストラリアの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • オーストラリアの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第13章 インドネシアの抗体薬物複合体 (ADC) 市場

  • インドネシアの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • インドネシアの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • インドネシアの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第14章 韓国の抗体薬物複合体 (ADC) 市場

  • 韓国の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 韓国の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 韓国の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第15章 西欧の抗体薬物複合体 (ADC) 市場

  • 西欧の抗体薬物複合体 (ADC) 市場概要
  • 西欧の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 西欧の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 西欧の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第16章 英国の抗体薬物複合体 (ADC) 市場

  • 英国の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 英国の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 英国の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第17章 ドイツの抗体薬物複合体 (ADC) 市場

  • ドイツの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • ドイツの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • ドイツの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第18章 フランスの抗体薬物複合体 (ADC) 市場

  • フランスの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • フランスの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • フランスの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第19章 東欧の抗体薬物複合体 (ADC) 市場

  • 東欧の抗体薬物複合体 (ADC) 市場概要
  • 東欧の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 東欧の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 東欧の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第20章 ロシアの抗体薬物複合体 (ADC) 市場

  • ロシアの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • ロシアの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • ロシアの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第21章 北米の抗体薬物複合体 (ADC) 市場

  • 北米の抗体薬物複合体 (ADC) 市場概要
  • 北米の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 北米の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 北米の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第22章 米国の抗体薬物複合体 (ADC) 市場

  • 米国の抗体薬物複合体 (ADC) 市場概要
  • 米国の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 米国の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 米国の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第23章 南米の抗体薬物複合体 (ADC) 市場

  • 南米の抗体薬物複合体 (ADC) 市場概要
  • 南米の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 南米の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 南米の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第24章 ブラジルの抗体薬物複合体 (ADC) 市場

  • ブラジルの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • ブラジルの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • ブラジルの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第25章 中東の抗体薬物複合体 (ADC) 市場

  • 中東の抗体薬物複合体 (ADC) 市場概要
  • 中東の抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • 中東の抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • 中東の抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第26章 アフリカの抗体薬物複合体 (ADC) 市場

  • アフリカの抗体薬物複合体 (ADC) 市場概要
  • アフリカの抗体薬物複合体 (ADC) 市場:タイプ別、実績と予測 (金額)
  • アフリカの抗体薬物複合体 (ADC) 市場:適応別、実績と予測 (金額)
  • アフリカの抗体薬物複合体 (ADC) 市場:製品別、実績と予測 (金額)

第27章 抗体薬物複合体 (ADC) 市場の競合情勢と企業プロファイル

  • 抗体薬物複合体 (ADC) 市場の競合情勢
  • 抗体薬物複合体 (ADC) 市場の企業プロファイル
    • Bayer AG
    • Concortis Biotherapeutics
    • F. Hoffman-La Roche Ltd.
    • Immunomedics, Inc.
    • Oxford BioTherapeutics

第28章 抗体薬物複合体 (ADC) のパイプライン分析

第29章 抗体薬物複合体 (ADC) 市場における主要なM&A

第30章 抗体薬物複合体 (ADC) 市場の将来見通しと潜在的分析

第31章 付録

目次
Product Code: h886

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antibody drug conjugates market.

The report focuses on the antibody drug conjugates market which is experiencing strong growth. The report gives a guide to the antibody drug conjugates market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antibody drug conjugates? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antibody Drug Conjugates Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others

2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others

3) By Product: Adcertis; Kadcyla; Others

4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others

5) By End User: Hospital; Clinics; Others

Companies Mentioned: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; Immunomedics; Oxford BioTherapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antibody Drug Conjugates Market Characteristics

3. Antibody Drug Conjugates Market Trends And Strategies

4. Impact Of COVID-19 On Antibody Drug Conjugates

5. Antibody Drug Conjugates Market Size And Growth

  • 5.1. Global Antibody Drug Conjugates Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Antibody Drug Conjugates Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Antibody Drug Conjugates Market Segmentation

  • 6.1. Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal Antibodies
  • Linker
  • Drug/Toxin
  • Others
  • 6.2. Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Brain Tumor
  • Others
  • 6.3. Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Adcertis
  • Kadcyla
  • Others
  • 6.4. Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immunogen Technology
  • Seattle Genetics Technology
  • Immunomedics Technology
  • Others
  • 6.5. Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics
  • Others

7. Antibody Drug Conjugates Market Regional And Country Analysis

  • 7.1. Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antibody Drug Conjugates Market

  • 8.1. Asia-Pacific Antibody Drug Conjugates Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antibody Drug Conjugates Market

  • 9.1. China Antibody Drug Conjugates Market Overview
  • 9.2. China Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antibody Drug Conjugates Market

  • 10.1. India Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antibody Drug Conjugates Market

  • 11.1. Japan Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antibody Drug Conjugates Market

  • 12.1. Australia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antibody Drug Conjugates Market

  • 13.1. Indonesia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antibody Drug Conjugates Market

  • 14.1. South Korea Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antibody Drug Conjugates Market

  • 15.1. Western Europe Antibody Drug Conjugates Market Overview
  • 15.2. Western Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antibody Drug Conjugates Market

  • 16.1. UK Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antibody Drug Conjugates Market

  • 17.1. Germany Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antibody Drug Conjugates Market

  • 18.5. France Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antibody Drug Conjugates Market

  • 19.1. Eastern Europe Antibody Drug Conjugates Market Overview
  • 19.2. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antibody Drug Conjugates Market

  • 20.1. Russia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antibody Drug Conjugates Market

  • 21.1. North America Antibody Drug Conjugates Market Overview
  • 21.2. North America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antibody Drug Conjugates Market

  • 22.1. USA Antibody Drug Conjugates Market Overview
  • 22.2. USA Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antibody Drug Conjugates Market

  • 23.1. South America Antibody Drug Conjugates Market Overview
  • 23.2. South America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antibody Drug Conjugates Market

  • 24.1. Brazil Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antibody Drug Conjugates Market

  • 25.1. Middle East Antibody Drug Conjugates Market Overview
  • 25.2. Middle East Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antibody Drug Conjugates Market

  • 26.1. Africa Antibody Drug Conjugates Market Overview
  • 26.2. Africa Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles

  • 27.1. Antibody Drug Conjugates Market Competitive Landscape
  • 27.2. Antibody Drug Conjugates Market Company Profiles
    • 27.2.1. Bayer AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Concortis Biotherapeutics
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffman-La Roche Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Immunomedics, Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Oxford BioTherapeutics
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Antibody Drug Conjugates Pipeline Analysis

29. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market

30. Antibody Drug Conjugates Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer